Assessing the extent of contamination in the Canadian National Breast Screening Study

Am J Prev Med. 1998 Oct;15(3):206-11. doi: 10.1016/s0749-3797(98)00074-9.

Abstract

Objective: To estimate the proportion of Canadian National Breast Screening Study (NBSS) participants who went outside the trial for a mammogram, based on health insurance claims data.

Method: Prospective cohort study linking trial subjects with population-based administrative data.

Subjects: All NBSS participants enrolled in the Winnipeg screening center who had health insurance claims to Manitoba Health (n = 9,780).

Analysis: Claims for bilateral mammograms were compared by screening arm allocation and age group at enrollment. Mammograms likely to be "screening" were defined based on prior claim history.

Results: For women aged 40 to 49 at enrollment, 5.3% in the intervention group and 21.8% in the control group had a claim for at least one bilateral mammogram. After excluding nonscreening mammograms these proportions fell to 2.2% and 14.1% (P < 0.0001). For women aged 50 to 59, 4.5% in the intervention group and 16.7% of the control group had at least one claim for a bilateral mammogram. These proportions were 2.1% and 10.5% for screening (P < 0.0001).

Conclusion: Health care utilization data can be used to estimate contamination in a screening trial. The levels of contamination resulting from participants going outside the study for a screening test can have an impact on the power of the study and need to be considered when interpreting results and planning future screening studies.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Breast Neoplasms / prevention & control*
  • Clinical Trials as Topic*
  • Female
  • Humans
  • Manitoba
  • Mass Screening*
  • Middle Aged
  • Treatment Refusal*